Daito Pharmaceutical Co (TSE:4577) Long-Term Debt: 円4,403 Mil (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4577 Daito Pharmaceutical Co Ltd TSE:4577
71 GF Score
Price 円1,271.00
GF Value 円1,279.24
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Daito Pharmaceutical Co Long-Term Debt?

Daito Pharmaceutical Co TSE:4577 -1.78% 71 Long-Term Debt is 円4,403 Mil as of Feb. 2026. GuruFocus rates TSE:4577 with a GF Score™ of 71/100 and a GF Value™ of 円1,279.24 (Fairly Valued). The stock has 3 warning signs investors should review.

Daito Pharmaceutical Co's Long-Term Debt for the quarter that ended in Feb. 2026 was 円4,403 Mil.

Daito Pharmaceutical Co's quarterly Long-Term Debt declined from Aug. 2025 (円5,844 Mil) to Nov. 2025 (円5,119 Mil) and declined from Nov. 2025 (円5,119 Mil) to Feb. 2026 (円4,403 Mil).

Daito Pharmaceutical Co's annual Long-Term Debt increased from May. 2024 (円4,669 Mil) to May. 2025 (円6,569 Mil) but then declined from May. 2025 (円6,569 Mil) to May. 2026 (円3,753 Mil).

Daito Pharmaceutical Co  (TSE:4577) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Daito Pharmaceutical Co Long-Term Debt Related Terms

Daito Pharmaceutical Co Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Daito Pharmaceutical Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daito Pharmaceutical Co Long-Term Debt Chart

Daito Pharmaceutical Co Annual Data
Trend May17 May18 May19 May20 May21 May22 May23 May24 May25 May26
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,247.00 3,368.00 4,669.00 6,569.00 3,753.00

Daito Pharmaceutical Co Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,569.00 5,844.00 5,119.00 4,403.00 3,753.00
TSE:4577
71GF Score
Daito Pharmaceutical Co Ltd TSE:4577
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of 円4,403 Mil mean?
Daito Pharmaceutical Co (TSE:4577) has a Long-Term Debt of 円4,403 Mil as of Feb. 2026.
Is Daito Pharmaceutical Co's Long-Term Debt too high?
Daito Pharmaceutical Co's current Long-Term Debt is 円4,403 Mil. Overall, Daito Pharmaceutical Co has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Daito Pharmaceutical Co's Long-Term Debt compare to ZTS and UTHR?
Daito Pharmaceutical Co's Long-Term Debt of 円4,403 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Drug Manufacturers company?
A good Long-Term Debt depends on the Drug Manufacturers industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Daito Pharmaceutical Co's current Long-Term Debt is 円4,403 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daito Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Daito Pharmaceutical Co (TSE:4577) is currently considered Fairly Valued. The stock's GF Value™ is 円1,279.24, compared to a current price of 円1,271.00 — trading 0.6% below its estimated fair value. The current Long-Term Debt is 円4,403 Mil. Daito Pharmaceutical Co's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Daito Pharmaceutical Co (TSE:4577), the current Long-Term Debt is 円4,403 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Daito Pharmaceutical Co (TSE:4577) Overvalued in 2026?

Based on GuruFocus' analysis, Daito Pharmaceutical Co stock appears to be undervalued. The current stock price of 円1,271.00 is trading 0.6% below its estimated GF Value™ of 円1,279.24. GuruFocus considers Daito Pharmaceutical Co to be Fairly Valued.

Key valuation signals for TSE:4577:

  • Long-Term Debt: 円4,403 Mil
  • GF Value™: 円1,279.24 vs. price of 円1,271.00 (0.6% below fair value)
  • GF Score™: 71/100 with 3 warning signs

No single metric tells the full story. See the TSE:4577 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Daito Pharmaceutical Co Business Description

Address 326 Yokamachi, Toyama, JPN, 939-8567
Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.
71GF Score

Get the complete analysis for TSE:4577

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,271.00
Price
円1,279.24
GF Value